Skip to main navigation Skip to search Skip to main content

Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesions

  • E. Javier Pretell
  • , Héctor H. García
  • , Robert H. Gilman
  • , Herbert Saavedra
  • , Manuel Martinez
  • , S. Rodriguez
  • , C. Padilla
  • , M. Porras
  • , A. E. Gonzalez
  • , M. Verastegui
  • , C. Evans
  • , V. C.W. Tsang
  • Instituto Nacional de Ciencias Neurológicas
  • Asociación Benéfica PRISMA
  • Universidad Peruana Cayetano Heredia
  • Johns Hopkins Bloomberg School of Public Health
  • Univ. Nacional Mayor de San Marcos
  • Imperial College of Medicine
  • Centers for Disease Control and Prevention

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

A recently described one-day regimen of praziquantel (PZQ) therapy for neurocysticercosis (NCC), three doses of 25 mg/k given at 2 h intervals, was applied in eight patients with viable NCC cysts without any evidence of inflammation. Resolution of lesions in computed tomography (CT) was observed in all five patients with a single cyst, whereas all cysts survived in three patients with multiple brain parasites. One-day praziquantel is a good regimen for patients with a single viable brain cysticercus but is poorly effective for multiple cysts.

Original languageEnglish
Article number968
Pages (from-to)175-177
Number of pages3
JournalClinical Neurology and Neurosurgery
Volume103
Issue number3
DOIs
StatePublished - 2001

Keywords

  • Cysticercosis
  • Neurocysticercosis
  • Praziquantel
  • Taenia solium

Fingerprint

Dive into the research topics of 'Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesions'. Together they form a unique fingerprint.

Cite this